Immune modulator drugs improves survival for people hospitalised with COVID-19
NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.